Radiation is a critical treatment component for the cure of around half of cancer patients. The predominant effect of radiotherapy is through death of tumour cells, however it is increasingly ...

A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary ...

LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS today presented a late-breaking poster titled “Significant cytotoxic and immunomodulatory effects of continuous low-dose intravesical gemcitabine in rodent ...